AGT M235T variant is not associated with risk of cancer

Conclusion
The present meta-analysis demonstrated that AGT M235T variant was not associated with risk of all cancer or various cancers. Further well-designed studies with large sample size should be conducted to confirm or refute the non-significant association.

Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - June 12, 2015 Category: Biomedical Science Authors: Lin, J., Chen, J., Liu, C. Tags: Original Articles Source Type: research